Gene · 1763
Papers1,643
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,643
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CaMKK2 and CHK1 phosphorylate human STN1 in response to replication stress to protect stalled forks from aberrant resection. | Nat Commun | 2023 | 38036565 | PubTator, text mining | PubMed |
| Highly sensitive detection of circulating tumour cells based on an ASV/CV dual-signal electrochemical strategy. | RSC Adv | 2023 | 38025856 | PubTator, text mining | PubMed |
| Rothmund-Thomson syndrome, a disorder far from solved. | Front Aging | 2023 | 38021400 | PubTator, text mining | PubMed |
| Azo Reductase Activated Magnetic Resonance Tuning Probe with "Switch-On" Property for Specific and Sensitive Tumor Imaging in Vivo. | ACS Nano | 2023 | 37991343 | PubTator, text mining | PubMed |
| SARS-CoV-2 helicase might interfere with cellular nonsense-mediated RNA decay: insights from a bioinformatics study. | BMC Genom Data | 2023 | 37980504 | PubTator, text mining | PubMed |
| Targeting the DNA Damage Response for Cancer Therapy. | Int J Mol Sci | 2023 | 37958890 | PubTator, text mining | PubMed |
| Checkpoint phosphorylation sites on budding yeast Rif1 protect nascent DNA from degradation by Sgs1-Dna2. | PLoS Genet | 2023 | 37956214 | PubTator, text mining | PubMed |
| Fanconi anemia-associated mutation in RAD51 compromises the coordinated action of DNA-binding and ATPase activities. | J Biol Chem | 2023 | 37924868 | PubTator, text mining | PubMed |
| Interplay between the DNA damage response and the life cycle of DNA tumor viruses. | Tumour Virus Res | 2023 | 37918513 | PubTator, text mining | PubMed |
| Human HELQ regulates DNA end resection at DNA double-strand breaks and stalled replication forks. | Nucleic Acids Res | 2023 | 37897354 | PubTator, text mining | PubMed |
| Recent Advancements in Development and Therapeutic Applications of Genome-Targeting Triplex-Forming Oligonucleotides and Peptide Nucleic Acids. | Pharmaceutics | 2023 | 37896275 | PubTator, text mining | PubMed |
| Combination Treatment Strategies to Overcome PARP Inhibitor Resistance. | Biomolecules | 2023 | 37892162 | PubTator, text mining | PubMed |
| RAD51 paralogs synergize with RAD51 to protect reversed forks from cellular nucleases. | Nucleic Acids Res | 2023 | 37843130 | PubTator, text mining | PubMed |
| The cancer testes antigen, HORMAD1, limits genomic instability in cancer cells by protecting stalled replication forks. | J Biol Chem | 2023 | 37838177 | PubTator, text mining | PubMed |
| New Facets of DNA Double Strand Break Repair: Radiation Dose as Key Determinant of HR versus c-NHEJ Engagement. | Int J Mol Sci | 2023 | 37834403 | PubTator, text mining | PubMed |
| Single-Nucleotide Polymorphisms in Genes Maintaining the Stability of Mitochondrial DNA Affect the Occurrence, Onset, Severity and Treatment of Major Depressive Disorder. | Int J Mol Sci | 2023 | 37834200 | PubTator, text mining | PubMed |
| CRISPR-Cas9 Direct Fusions for Improved Genome Editing via Enhanced Homologous Recombination. | Int J Mol Sci | 2023 | 37834150 | PubTator, text mining | PubMed |
| Multi-step processing of replication stress-derived nascent strand DNA gaps by MRE11 and EXO1 nucleases. | Nat Commun | 2023 | 37805499 | PubTator, text mining | PubMed |
| ATR-binding lncRNA ScaRNA2 promotes cancer resistance through facilitating efficient DNA end resection during homologous recombination repair. | J Exp Clin Cancer Res | 2023 | 37775817 | PubTator, text mining | PubMed |
| Targeting DNA Damage Repair and Immune Checkpoint Proteins for Optimizing the Treatment of Endometrial Cancer. | Pharmaceutics | 2023 | 37765210 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1763/papers?page=7